Santander UK Plc
29 July 2026
SANTANDER UK PLC
€35 BILLION GLOBAL COVERED BOND PROGRAMME
Publication of Final Terms - Series 88 Tranche 2
The following final terms (the Final Terms) are available for viewing:
Issue of Series 88 Tranche 2 €400,000,000 Fixed Rate Covered Bonds due May 2031 (XS3454380760) (the Covered Bonds) to be consolidated, become fungible and form a single series with the existing Series 88 Tranche 1 €1,000,000,000 Fixed Rate Covered Bonds due May 2031 (XS2823118018) issued on 20 May 2024 under the €35 billion Global Covered Bond Programme of Santander UK plc (the Programme).
To view the full Final Terms, please click on or paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/4378O_1-2026-7-29.pdf
A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Final Terms can also be viewed at: https://www.santander.co.uk/uk/about-santander-uk/debt-investors/santander-uk-covered-bonds.
Please see Annex 1 to this notice for additional information in relation to the Covered Bonds.
For further information, please contact:
Funding, Asset Rotation and Investor Relations
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN
Email: FAIR@santander.co.uk
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms and the base prospectus published in respect of the Programme on 17 March 2026 as supplemented on 1 May 2026, 8 May 2026, 5 June 2026 and 22 July 2026 (the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus you must ascertain from the Final Terms and the Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement.
ANNEX 1
ADDITIONAL INFORMATION IN RELATION TO SERIES 88 TRANCHE 2 €400,000,000 FIXED RATE COVERED BONDS DUE MAY 2031 TO BE CONSOLIDATED, BECOME FUNGIBLE AND FORM A SINGLE SERIES WITH THE EXISTING SERIES 88 TRANCHE 1 €1,000,000,000 FIXED RATE COVERED BONDS DUE MAY 2031 ISSUED ON 20 MAY 2024
OPERATIONAL INFORMATION DOCUMENT
This Operational Information Document related to the Final Terms dated 29 July 2029 (the Final Terms) in respect of the issue of Series 88 Tranche 2 €400,000,000 Floating Rate Covered Bonds due May 2031 (XS3454380760) to be consolidated, become fungible and form a single series with the existing Series 88 Tranche 1 €1,000,000,000 Fixed Rate Covered Bonds due May 2031 (XS2823118018) issued on 20 May 2024.
This Operational Information Document has not been reviewed or approved by the FCA for the purposes of the rules in the Prospectus Rules: Admission to Trading on a Regulated Market sourcebook (the PRM) or otherwise and does not form part of the Final Terms for the purposes of the PRM. However, for all other purposes this Operational Information Document must be read in conjunction with the Final Terms. Words and expressions which have a defined meaning in the Final Terms or Base Prospectus dated 17 March 2026 as supplemented on 1 May 2026, 8 May, 5 June 2026 and 22 July 2026 and have the same meanings in this Operational Information Document.
DISTRIBUTION
(a) If syndicated, names of Joint Lead Managers: Not Applicable
(b) Date of Subscription Agreement: Not Applicable
(c) If not syndicated, name of relevant Dealer: Banco Santander, S.A.
(d) U.S. Selling Restrictions: Regulation S
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.